LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 51 filers reported holding LEGEND BIOTECH CORP in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 16,351 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | – | 16,351 | -5.8% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 17,351 | -16.0% | 0.00% | -100.0% |
| Q4 2022 | $843 | -99.9% | 20,659 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $843,000 | -30.2% | 20,659 | -6.0% | 0.00% | -33.3% |
| Q2 2022 | $1,208,000 | +1.2% | 21,968 | -33.2% | 0.01% | +50.0% |
| Q1 2022 | $1,194,000 | -0.8% | 32,865 | +27.2% | 0.00% | 0.0% |
| Q4 2021 | $1,204,000 | +18.3% | 25,830 | +28.3% | 0.00% | 0.0% |
| Q3 2021 | $1,018,000 | -54.5% | 20,128 | -63.1% | 0.00% | 0.0% |
| Q2 2021 | $2,238,000 | +41.5% | 54,508 | 0.0% | 0.00% | +33.3% |
| Q1 2021 | $1,582,000 | -76.6% | 54,508 | +24.6% | 0.00% | 0.0% |
| Q4 2020 | $6,774,000 | +63.3% | 43,738 | -67.4% | 0.00% | -75.0% |
| Q3 2020 | $4,148,000 | – | 134,332 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $56,230,872 | 17.46% |
| Paradigm Biocapital Advisors LP | 1,805,717 | $124,648,645 | 9.63% |
| HHLR ADVISORS, LTD. | 6,436,533 | $444,313,873 | 9.46% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,692 | $77,568,459 | 9.09% |
| RA Capital Management | 6,264,707 | $432,452,724 | 8.16% |
| Tri Locum Partners LP | 116,768 | $8,060,495 | 3.00% |
| Nicholas Investment Partners, LP | 593,167 | $40,946,318 | 2.80% |
| E Fund Management (Hong Kong) Co., Ltd. | 51,679 | $3,567 | 2.66% |
| Avidity Partners Management LP | 798,900 | $55,148,067 | 1.93% |
| Boxer Capital, LLC | 600,000 | $41,418 | 1.92% |